Natural Antioxidants Exhibit Chemopreventive Characteristics through the Regulation of CNC b-Zip Transcription Factors in Estrogen-Induced Breast Carcinogenesis

Journal of Biochemical and Molecular Toxicology

Volumn 28, Issue 12, 2014, Pages 529-538

  Chatterjee, Anwesha ^a   Ronghe, Amruta ^a   Singh, Bhupendra ^b   Bhat, Nimee K ^a   Chen, Jie ^a   Bhat, Hari K ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Breast Cancer; CNC b zip Transcription Factors; Estrogen; Resveratrol; Vitamin C

Indexed keywords

ASCORBIC ACID; ESTRADIOL; MESSENGER RNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); RESVERATROL; SMALL INTERFERING RNA; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR CNC B-ZIP; TRANSCRIPTION FACTOR NRF1; TRANSCRIPTION FACTOR NRF2; TRANSCRIPTION FACTOR NRF3; UNCLASSIFIED DRUG; ANTIOXIDANT; BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; ESTROGEN; NQO1 PROTEIN, HUMAN; SOD3 PROTEIN, HUMAN; TUMOR PROTEIN;

ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; BREAST EPITHELIUM CELL; CHEMOPROPHYLAXIS; ESTROGEN THERAPY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REGULATORY MECHANISM; BIOSYNTHESIS; BREAST NEOPLASMS; CHEMICALLY INDUCED; DRUG EFFECTS; ENZYMOLOGY; FEMALE; GENE EXPRESSION REGULATION; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANTIOXIDANTS; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; BREAST NEOPLASMS; CELL LINE, TUMOR; ESTRADIOL; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NAD(P)H DEHYDROGENASE (QUINONE); NEOPLASM PROTEINS; SUPEROXIDE DISMUTASE;

EID: 84918838713     PISSN: 10956670     EISSN: 10990461     Source Type: Journal    
DOI: 10.1002/jbt.21594     Document Type: Article

References (55)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J Clin 2013;63(1):11-30.
2. Shinohara MM, Tozbikian G, Wolfe JT, Shin SJ, Mies C, Elenitsas R. Cutaneous metastatic breast carcinoma with clear cell features. J Cutan Pathol 2013;40(8):753-757.
3. Siegel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J Clin 2012;62(1):10-29.
4. Nelson R. Steroidal oestrogens added to list of known human carcinogens. Lancet 2002;360:2053.
5. Bhat HK, Han X, Gladek A, Liehr JG. Regulation of the formation of the major diethylstilbestrol-DNA adduct and some evidence of its structure. Carcinogenesis 1994;15(10):2137-2142.
6. Bhat HK, Calaf G, Hei TK, Loya T, Vadgama JV. Critical role of oxidative stress in estrogen-induced carcinogenesis. Proc Natl Acad Sci USA 2003;100:3913-3918.
7. Cavalieri E, Rogan E. Catechol quinones of estrogens in the initiation of breast, prostate, and other human cancers: keynote lecture. Ann N Y Acad Sci 2006;1089:286-301.
8. Clemons M, Goss P. Estrogen and the risk of breast cancer. N Engl J Med 2001;344:276-285.
9. Howell A. The endocrine prevention of breast cancer. Best Pract Res Clin Endocrinol Metab 2008;22:615-623.
10. Mense SM, Remotti F, Bhan A, Singh B, El-Tamer M, Hei TK, Bhat HK. Estrogen-induced breast cancer: alterations in breast morphology and oxidative stress as a function of estrogen exposure. Toxicol Appl Pharmacol 2008;232(1):78-85.
11. Mense SM, Singh B, Remotti F, Liu X, Bhat HK. Vitamin C and alpha-naphthoflavone prevent estrogen-induced mammary tumors and decrease oxidative stress in female ACI rats. Carcinogenesis 2009;30(7):1202-1208.
12. Patel MM, Bhat HK. Differential oxidant potential of carcinogenic and weakly carcinogenic estrogens: involvement of metabolic activation and cytochrome P450. J Biochem Mol Toxicol 2004;18:37-42.
13. Roy D, Liehr JG. Temporary decrease in renal quinone reductase activity induced by chronic administration of estradiol to male Syrian hamsters. Increased superoxide formation by redox cycling of estrogen. J Biol Chem 1988;263:3646-3651.
14. Russo J, Lareef MH, Tahin Q, Hu YF, Slater C, Ao X, Russo IH. 17Beta-estradiol is carcinogenic in human breast epithelial cells. J Steroid Biochem Mol Biol 2002;80:149-162.
15. Singh B, Mense SM, Remotti F, Liu X, Bhat HK. Antioxidant butylated hydroxyanisole inhibits estrogen-induced breast carcinogenesis in female ACI rats. J Biochem Mol Toxicol 2009;23:202-211.
16. Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer. N Engl J Med 2006;354:270-282.
17. Roy D, Liehr JG. Estrogen, DNA damage and mutations. Mutat Res 1999;424:107-115.
18. Yager JD. Endogenous estrogens as carcinogens through metabolic activation. J Natl Cancer Inst Monogr 2000;27:67-73.
19. Adlercreutz H. Phyto-oestrogens and cancer. Lancet Oncol 2002;3(6):364-373.
20. Probst-Hensch NM, Pike MC, McKean-Cowdin R, Stanczyk FZ, Kolonel LN, Henderson BE. Ethnic differences in post-menopausal plasma oestrogen levels: high oestrone levels in Japanese-American women despite low weight. Br J Cancer 2000;82(11):1867-1870.
21. Gikas PD, Mokbel K. Phytoestrogens and the risk of breast cancer: a review of the literature. Int J Fertil Womens Med 2005;50(6):250-258.
22. Singh B, Mense SM, Bhat NK, Putty S, Guthiel WA, Remotti F, Bhat HK. Dietary quercetin exacerbates the development of estrogen-induced breast tumors in female ACI rats. Toxicol Appl Pharmacol 2010;247(2):83-90.
23. Hinrichs B, Zahid M, Saeed M, Ali MF, Cavalieri EL, Rogan EG. Formation of diethylstilbestrol-DNA adducts in human breast epithelial cells and inhibition by resveratrol. J Steroid Biochem Mol Biol 2011;127(3-5):276-281.
24. Garvin S, Ollinger K, Dabrosin C. Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo. Cancer Lett 2006;231:113-122.
25. Kao CL, Chen LK, Chang YL, Young MC, Hsu CC, Chen YC, Lo WL, Chen SJ, Ku HH, Hwang SJ. Resveratrol protects human endothelium from H(2)O(2)-induced oxidative stress and senescence via SirT1 activation. J Atheroscler Thromb 2010;17:970-979.
26. Mohammadshahi M, Haidari F, Ghadiri Soufi F. Chronic resveratrol administration improves diabetic cardiomyopathy in part by reducing oxidative stress. Cardiol J 2014;21(1):39-46.
27. Pruthi S, Yang L, Sandhu NP, Ingle JN, Beseler CL, Suman VJ, Cavalieri EL, Rogan EG. Evaluation of serum estrogen-DNA adducts as potential biomarkers for breast cancer risk. J Steroid Biochem Mol Biol 2012;132(1-2):73-79.
28. Singh B, Bhat NK, Bhat HK. Induction of NAD(P)H-quinone oxidoreductase by antioxidants in female ACI rats is associated with decrease in oxidative DNA damage and inhibition of estrogen-induced breast cancer. Carcinogenesis 2012;33:156-163.
29. Tang Q, Li G, Wei X, Zhang J, Chiu JF, Hasenmayer D, Zhang D, Zhang H. Resveratrol-induced apoptosis is enhanced by inhibition of autophagy in esophageal squamous cell carcinoma. Cancer Lett 2013;S0304-S3835(13):00251-00256.
30. Garvin S, Ollinger K, Dabrosin C. Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo. Cancer Lett 2006;231:113-122.
31. Kuo SM, Burl LR, Hu Z. Cellular phenotype-dependent and - independent effects of vitamin C on the renewal and gene expression of mouse embryonic fibroblasts. PLoS One 2012;7(3):e32957.
32. Mamede AC, Tavares SD, Abrantes AM, Trindade J, Maia JM, Botelho MF. The role of vitamins in cancer: a review. Nutr Cancer 2011;63(4):479-494.
33. Ullah MF, Khan HY, Zubair H, Shamim U, Hadi SM. The antioxidant ascorbic acid mobilizes nuclear copper leading to a prooxidant breakage of cellular DNA: implications for chemotherapeutic action against cancer. Cancer Chemother Pharmacol 2011;67(1):103-110.
34. Elbekai RH, Duke J, El-Kadi AO. Ascorbic acid differentially modulates the induction of heme oxygenase-1, NAD(P)H:quinone oxidoreductase 1 and glutathione S-transferase Ya by As(3+), Cd(2+) and Cr(6+). Cancer Lett 2007;246(1-2):54-62.
35. Kobayashi A, Ito E, Toki T, Kogame K, Takahashi S, Igarashi K, Hayashi N, Yamamoto M. Molecular cloning and functional characterization of a new Cap'n' collar family transcription factor Nrf3. J Biol Chem 1999;274(10):6443-6452.
36. Mathers J, Fraser JA, McMahon M, Saunders RD, Hayes JD, McLellan LI. Antioxidant and cytoprotective responses to redox stress. Biochem Soc Symp 2004;71:157-176.
37. Chevillard G, Blank V. NFE2L3 (NRF3): the Cinderella of the cap "n" collar transcription factors. Cell Mol Life Sci 2011;68:3337-3348.
38. Sykiotis GP, Bohmann D. Stress-activated cap "n" collar transcription factors in aging and human disease. Sci Signal 2010;3(112):re3.
39. Kensler TW, Wakabayashi N, Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol 2007;47:89-116.
40. Kaspar JW, Niture SK, Jaiswal AK. Nrf2:INrf2 (Keap1) signaling in oxidative stress. Free Radical Biol Med 2009;47:1304-1309.
41. Kwak MK, Itoh K, Yamamoto M, Kensler TW. Enhanced expression of the transcription factor Nrf2 by cancer chemopreventive agents: role of antioxidant response element-like sequences in the nrf2 promoter. Mol Cell Biol 2002;22:2883-2892.
42. Ramos-Gomez M, Kwak MK, Dolan PM, Itoh K, Yamamoto M, Talalay P, Kensler TW. Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proc Natl Acad Sci USA 2001;98:3410-3415.
43. Zhang DD. Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab Rev 2006;38:769-789.
44. Biswas M, Chan JY. Role of Nrf1 in antioxidant response element-mediated gene expression and beyond. Toxicol Appl Pharmacol 2010;244:16-20.
45. Han W, Ming M, Zhao R, Pi J, Wu C, He YY. Nrf1 CNC-bZIP protein promotes cell survival and nucleotide excision repair through maintaining glutathione homeostasis. J Biol Chem 2012;287:18788-18795.
46. Hernandez-Montes E, Pollard SE, Vauzour D, Jofre-Montseny L, Rota C, Rimbach G, Weinberg PD, Spencer JP. Activation of glutathione peroxidase via Nrf1 mediates genistein's protection against oxidative endothelial cell injury. Biochem Biophys Res Commun 2006;346:851-859.
47. Venugopal R, Jaiswal AK. Nrf2 and Nrf1 in association with Jun proteins regulate antioxidant response element-mediated expression and coordinated induction of genes encoding detoxifying enzymes. Oncogene 1998;17:3145-3156.
48. Wang W, Chan JY. Nrf1 is targeted to the endoplasmic reticulum membrane by an N-terminal transmembrane domain. J Biol Chem 2006;281:19676-19687.
49. Zhang Y, Crouch DH, Yamamoto M, Hayes JD. Negative regulation of the Nrf1 transcription factor by its N-terminal domain is independent of Keap1: Nrf1, but not Nrf2, is targeted to the endoplasmic reticulum. Biochem J 2006;399:373-385.
50. Sankaranarayanan K, Jaiswal AK. Nrf3 negatively regulates antioxidant- response element-mediated expression and antioxidant induction of NAD(P)H:quinone oxidoreductase1 gene. J Biol Chem 2004;279(49):50810-50817.
51. Singh B, Bhat HK. Superoxide dismutase 3 is induced by antioxidants, inhibits oxidative DNA damage and is associated with inhibition of estrogen-induced breast cancer. Carcinogenesis 2012;33(12):2601-2610.
52. Bhat HK, Hacker HJ, Thompson EB, Liehr JG. Differential regulation by estrogen of c-fos in hamster kidney and estrogen-induced kidney tumor cells: receptor mediation vs. metabolic activation. Int J Oncol 1995;7:527-534.
53. Bhat HK, Epelboym I. Quantitative analysis of total mitochondrial DNA: competitive polymerase chain reaction vs. real-time polymerase chain reaction. J Biochem Mol Toxicol 2004;1118:180-186.
54. Singh B, Chatterjee A, Ronghe AM, Bhat NK, Bhat HK. Antioxidants-mediated upregulation of OGG1 via NRF2 induction is associated with prevention of oxidative DNA damage in estrogen-induced breast cancer. BMC Cancer 2013;13:253-261.
55. Singh B, Ronghe AM, Chatterjee A, Bhat NK, Bhat HK. MicroRNA-93 regulates NRF2 expression and is associated with breast carcinogenesis. Carcinogenesis 2013;34:1165-1172.